Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grace Lu-Yao

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
European Urology|February 27, 2013
Words of wisdom: re: radical prostatectomy versus observation for localized prostate cancerGrace Lu-Yao
Journal of the National Cancer Institute|July 4, 2002
Understanding and appreciating overdiagnosis in the PSA eraSiu-Long Yao, Grace Lu-Yao
International Journal of Radiation Oncology, Biology, Physics|January 15, 2013
In regard to Shen et alYu-Hsuan Joni Shao, Grace Lu-Yao
The Journal of Urology|May 6, 2004
Changing patterns in competing causes of death in men with prostate cancer: a population based studyGrace Lu-Yao, Therese A Stukel, Siu-Long Yao
Journal of the National Cancer Institute|December 5, 2003
Prostate-specific antigen screening in elderly menGrace Lu-Yao, Therese A Stukel, Siu-Long Yao
JAMA|January 8, 2009
Failure to report financial disclosure informationGrace Lu-Yao, Peter Albertsen, Weichung Shih, et al.
The American Journal of Medicine|August 31, 2010
Obesity and prostate cancer detection: insights from three national surveysNiyati Parekh, Yong Lin, Robert S Dipaola, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 5, 2008
Associations of lifestyle and physiologic factors with prostate-specific antigen concentrations: evidence from the National Health and Nutrition Examination Survey (2001-2004)Niyati Parekh, Yong Lin, Stephen Marcella, et al.
Cancers|September 23, 2022
Epigenetic Dysregulations in Arsenic-Induced CarcinogenesisRanakul Islam, Lei Zhao, Yifang Wang, et al.
Plos One|August 29, 2022
A scoping review protocol to elucidate outcomes following abiraterone versus enzalutamide for prostate cancerYash B Shah, Amy L Shaver, William Kevin Kelly, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
European Urology|February 27, 2013
Words of wisdom: re: radical prostatectomy versus observation for localized prostate cancerGrace Lu-Yao
Journal of the National Cancer Institute|July 4, 2002
Understanding and appreciating overdiagnosis in the PSA eraSiu-Long Yao, Grace Lu-Yao
International Journal of Radiation Oncology, Biology, Physics|January 15, 2013
In regard to Shen et alYu-Hsuan Joni Shao, Grace Lu-Yao
The Journal of Urology|May 6, 2004
Changing patterns in competing causes of death in men with prostate cancer: a population based studyGrace Lu-Yao, Therese A Stukel, Siu-Long Yao
Journal of the National Cancer Institute|December 5, 2003
Prostate-specific antigen screening in elderly menGrace Lu-Yao, Therese A Stukel, Siu-Long Yao
JAMA|January 8, 2009
Failure to report financial disclosure informationGrace Lu-Yao, Peter Albertsen, Weichung Shih, et al.
The American Journal of Medicine|August 31, 2010
Obesity and prostate cancer detection: insights from three national surveysNiyati Parekh, Yong Lin, Robert S Dipaola, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 5, 2008
Associations of lifestyle and physiologic factors with prostate-specific antigen concentrations: evidence from the National Health and Nutrition Examination Survey (2001-2004)Niyati Parekh, Yong Lin, Stephen Marcella, et al.
Cancers|September 23, 2022
Epigenetic Dysregulations in Arsenic-Induced CarcinogenesisRanakul Islam, Lei Zhao, Yifang Wang, et al.
Plos One|August 29, 2022
A scoping review protocol to elucidate outcomes following abiraterone versus enzalutamide for prostate cancerYash B Shah, Amy L Shaver, William Kevin Kelly, et al.
Pageof 5